Effects of transforming growth factor-β3 and matrix metalloproteinase-3 on the pathogenesis of chronic mitral valvular disease in dogs

American Journal of Veterinary Research

Volumn 72, Issue 2, 2011, Pages 194-202

  Obayashi, Koji ^a,b   Miyagawa Tomita, Sachiko ^b   Matsumoto, Hirotaka ^a   Koyama, Hidekazu ^a   Nakanishi, Toshio ^b   Hirose, Hisashi ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BENAZEPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CAUSE OF DEATH; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOG; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; MALE; MARFAN SYNDROME; MITRAL VALVE DISEASE; MITRAL VALVE PROLAPSE; NONHUMAN; PATHOGENESIS; VALVULAR HEART DISEASE; WESTERN BLOTTING;

ANIMALS; CHRONIC DISEASE; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION; HYDROCORTISONE; MALE; MATRIX METALLOPROTEINASE 3; MITRAL VALVE INSUFFICIENCY; PROTEIN ISOFORMS; TRANSFORMING GROWTH FACTOR BETA3;

CANIS FAMILIARIS;

EID: 79951915137     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.2.194     Document Type: Article

References (40)

1. Darke PG. Valvular incompetence in Cavalier King Charles Spaniels. Vet Rec 1987;120:365-366.
2. Beardow AW, Buchanan JW. Chronic mitral valve disease in Cavalier King Charles Spaniels: 95 cases (1987-1991). J Am Vet Med Assoc 1993;203:1023-1029.
3. Devereux RB. Recent developments in the diagnosis and management of mitral valve prolapse. Curr Opin Cardiol 1995;10:107-116.
4. Fontana ME, Sparks EA, Boudoulas H, et al. Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Probl Cardiol 1991;16:309-375.
5. King BD, Clark MA, Baba N, et al. "Myxomatous" mitral valves: collagen dissolution as the primary defect. Circulation 1982;66:288-296. (Pubitemid 12084976)
6. Rabkin E, Aikawa M, Stone J, et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001;104:2525-2532. (Pubitemid 33104788)
7. Corcoran BM, Black A, Anderson H, et al. Identification of surface morphologic changes in the mitral valve leaflets and chordae tendineae of dogs with myxomatous degeneration. Am J Vet Res 2004;65:198-206. (Pubitemid 38312755)
8. Black A, French AT, Dukes-McEwan J, et al. Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve. Am J Vet Res 2005;66:1408-1414. (Pubitemid 41613995)
9. Disatian S, Ehrhart EJ III, Zimmerman S, et al. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation. J Heart Valve Dis 2008;17:402-411.
10. Han RI, Black A, Culshaw GJ, et al. Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease. Am J Vet Res 2008;69:763-769. (Pubitemid 351891272)
11. Weber H, Webb ML, Serafino R, et al. Endothelin-1 and angiotensin- II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol 1994;8:148-158. (Pubitemid 24067102)
12. Rizvi MA, Katwa L, Spadone DP, et al. The effects of endothelin- 1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol 1996;28:243-252. (Pubitemid 26110469)
13. Mow T, Pedersen HD. Increased endothelin-receptor density in myxomatous canine mitral valve leaflets. J Cardiovasc Pharmacol 1999;34:254-260. (Pubitemid 29350507)
14. Olsen LH, Mortensen K, Martinussen T, et al. Increased NADPH-diaphorase activity in canine myxomatous mitral valve leaflets. J Comp Pathol 2003;129:120-130. (Pubitemid 37069326)
15. Aupperle H, Thielebein J, Kiefer B, et al. An immunohistochemical study of the role of matrix metalloproteinases and their tissue inhibitors in chronic mitral valvular disease (valvular endocardiosis) in dogs. Vet J 2009;180:88-94.
16. Aupperle H, Marz I, Thielebein J, et al. Expression of transforming growth factor-beta1, -beta2 and -beta3 in normal and diseased canine mitral valves. J Comp Pathol 2008;139:97-107.
17. Mahimkar R, Nguyen A, Mann M, et al. Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease. Cardiovasc Pathol 2009;18:253-261.
18. Ng CM, Cheng A, Myers LA, et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004;114:1586-1592. (Pubitemid 40385549)
19. Dreger SA, Taylor PM, Allen SP, et al. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. J Heart Valve Dis 2002;11:875-880. (Pubitemid 35422618)
20. Annes J, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003;116:217-224. (Pubitemid 36163863)
21. Kaartinen V, Warburton D. Fibrillin controls TGF-beta activation. Nat Genet 2003;33:331-332.
22. Charbonneau NL, Ono RN, Corson GM, et al. Fine tuning of growth factor signals depends on fibrillin microfibril networks. Birth Defects Res C Embryo Today 2004;72:37-50. (Pubitemid 38456570)
23. Ramirez F, Sakai L, Dietz H, et al. Fibrillin microfibrils: multi-purpose extracellular networks in organismal physiology. Physiol Genomics 2004;19:151-154. (Pubitemid 40039921)
24. Rifkin DB. Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 2005;280:7409-7412. (Pubitemid 40349631)
25. Togashi M, Tamura K, Nitta T, et al. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves. Pathol Int 2007;57:251-259. (Pubitemid 46595029)
26. Buchanan JW. Patent ductus arteriosus. Semin Vet Med Surg (Small Anim) 1994;9:168-176.
27. Buchanan JW, Bücheler J. Vertebral scale system to measure canine heart size in radiographs. J Am Vet Med Assoc 1995;206:194-199.
28. Pouchelon JL, Jamet N, Gouni V, et al. Effect of Benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases. J Vet Intern Med 2008;22:905-914. (Pubitemid 352039173)
29. Whitney JC. Cardiovascular pathology. J Small Anim Pract 1967;8:459-465.
30. Pho M, Lee W, Watt DR, et al. Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves. Am J Physiol Heart Circ Physiol 2008;294:1767-1778.
31. Tamura K, Fukuda Y, Ishizaki M, et al. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J 1995;129:1149-1158.
32. Mercado-Pimentel ME, Runyan RB. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 2007;185:146-156. (Pubitemid 46956855)
33. Norris RA, Potts JD, Yost MJ, et al. Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn 2009;238:1052-1063.
34. Pho M, Lee W, Watt DR, et al. Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves. Am J Physiol Heart Circ Physiol 2008;294:H1767-H1778. (Pubitemid 351490607)
35. Neidlinger-Wilke C, Würtz K, Urban JP, et al. Regulation of gene expression in intervertebral disc cells by low and high hydrostatic pressure. Eur Spine J 2006;15(suppl 3):S372-S378. (Pubitemid 44371016)
36. Das RH, Jahr H, Verhaar JA, et al. In vitro expansion affects the response of chondrocytes to mechanical stimulation. Osteoarthritis Cartilage 2008;16:385-391. (Pubitemid 351309187)
37. Li XC, Zhuo JL. Intracellular ANG II directly induces in vitro transcription of TGF-beta1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors. Am J Physiol Cell Physiol 2008;294:C1034-C1045. (Pubitemid 351507913)
38. Zhang N, Wu XY, Wu XP, et al. Relationship between age-related serum concentrations of TGF-beta1 and TGF-beta2 and those of osteoprotegerin and leptin in native Chinese women. Clin Chim Acta 2009;403:63-69.
39. Hering S, Isken F, Janott J, et al. Analysis of TGF-β3 gene expression and protein levels in human bone and serum. Exp Clin Endocrinol Diabetes 2001;109:107-115. (Pubitemid 32294578)
40. Bonnema DD, Webb CS, Pennington WR, et al. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). J Card Fail 2007;13:530-540. (Pubitemid 47371209)